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Post-operative survival was derived from our own database, Cancer 
Registry and Hospital records.
Statistical analysis using SPSS v14 was used to perform Cox regres-
sion analyses and plot survival curves. For the purposes of analyses, 
proportions of each tumour pattern were classiﬁed as ‘low, medium or 
high’ using thresholds of 33 and 67%, or 20 and 50% respectively and 
as ‘low or high’ using thresholds of 30% or 50% respectively. 
Results: 58% of patients were male. Maximum tumour diameter 
ranged from 0.4 cm to 11 cm. Tumours were pathologically Stage I in 
51 %, Stage II in 33 % and Stage III in 15 %. The acinar pattern pre-
dominated in 78 cases (46%), solid pattern in 37 cases (22%), BAC in 
29 cases (17%) and papillary pattern predominated in 19 cases (11%). 
Furthermore each pattern accounted for more than 50% of the tumour 
as follows (cases / %); acinar (57 / 33%), solid (34 / 20%), BAC (16 / 
9.4%), papillary (13 / 7.6%).
Female gender (P = 0.003 ) and increasing Stage (P = 0.007 ) were 
signiﬁcantly associated with post-operative survival. No signiﬁcant 
association could be found between the distribution of different tumour 
patterns in this study. Patients with predominantly BAC-pattern adeno-
carcinomas are more likely to be alive at 5 years (P = 0.03).
There are trends (not statistically signiﬁcant) suggesting that when 
BAC is the predominant pattern or accounts for over 50% of the tu-
mour, survival is longer (P = 0.13 and 0.07 respectively) and that when 
adenocarcinoma is predominantly or more than 50% solid, or predomi-
nantly papillary, survival is worse (P = 0.35, 0.25, 0.32). Yet tumours 
with over 50% papillary pattern tended towards longer survival (P = 
0.13). A trend of worsening survival was seen, from predominantly 
BAC tumours, where survival was longest, followed in order by acinar, 
solid and papillary adenocarcinomas demonstrating increasingly poor 
survival. Again this trend failed to reach statistical signiﬁcance. 
Conclusion: In this series of surgically resected pulmonary adenocar-
cinomas, there was no signiﬁcant association between post-operative 
survival and the patterns of adenocarcinoma identiﬁed and their relative 
frequency. 
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Background: Recent data shows that chronic inﬂammation leads to 
carcinogenesis in some organ. On the contrary the others suggest that 
inﬂammatory cells may delay tumor progression or destroy tumor cells 
by inﬁltrating to host tissue and inducing local immunologic response. 
And it is well known that smoking has relation to chronic inﬂammation 
of airway as well as lung cancer. The aim of this study is to elucidate 
association between the severity of inﬂammation in resected lung tissue 
and prognosis in patients with Non-small cell lung cancer. 
Methods: Patients who had undergone lung resectional surgery for the 
treatment of Non-small cell lung cancer at Seoul National University 
Hospital between December 1999 and January 2002 were included. 
We retrospectively reviewed the medical records including survival 
and pathologic results. Inﬂammatory inﬂammations of lung tissue were 
grouped into 3 categories (mild, moderate and severe) according to 
lymphoid follicles surrounding tumor or tumor parenchyma as well as 
inﬁltration of inﬂammatory cells between tumor islets by microscopic 
review. 
Results: 231 patients with Non-small cell lung cancer were included. 
Median age was 61 years and 168 were male. Survival rates were ana-
lyzed by use of Kaplan-Meier estimation and the variables affected sur-
vival rates were analyzed by Cox-regression test. In the patients with 
adenocarcinoma, the patients with severe inﬂammatory inﬁltrations had 
more shorter survival (35.5 mon) than the patients with mild or moder-
ate inﬂammatory inﬁltrations (61.8 mon, p=0.02). On the other hand, 
in the patients with squamous cell carcinoma, the patients with severe 
inﬂammatory inﬁltrations had a tendency to survive more longer and it 
was apparent in non smoker, especially. But the overall survival rates 
was not signiﬁcantly different among three groups according to sever-
ity of inﬂammation (p=0.75). 
Conclusions: Severity of inﬂammation in primary tumor might have a 
role to predict the prognosis of some patients with Non-small cell lung 
cancer.
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Background: As screening is popular, a small pulmonary nodule is 
often detected. Since routine bronchoscopic biopsy does not always 
provide an accurate diagnosis of the lesion, thoracotomy is sometimes 
employed as a ﬁnal diagnostic procedure. The aim of this study is to 
evaluate the utility of intra-operative ﬁne needle aspiration (FNA) 
cytology using modiﬁed Shorr’s staining method for detecting the pres-
ence of malignancy and cell typing.
Materials and Methods: Intra-operative FNA cytology was performed 
in 57 patients who underwent surgery for suspected lung cancer from 
April 2001 to March 2007. The samples were stained by the modiﬁed 
Shorr’s staining method, where EA-50 dye was substituted for Shorr’s 
dye. Since the staining procedure and investigation are performed in 
the operating room by a cytologist, it takes the cytological examination 
process only 3 minutes.
Results: The patient’s demographics were 36 males and 21 females 
with a mean age of 65.5 years. Both malignancy and cell typing were 
diagnosed in 46 cases. The tumor prevalence was primary lung cancer 
in 41 cases and metastatic lung cancer in 5 cases. One case turned out 
only a malignancy. Since 10 cases were not revealed by cytology, intra-
operative histological study was added. Of the 10 cases, 5 were benign 
tumors including Cryptococcus in 2, Mycobacterium avium complex 
in 1, organizing pneumonia in 1, and nodular lymphoid hyperplasia in 
1. The other 5 cases were diagnosed as primary lung cancer including 
adenocarcinoma in 4 and squamous cell carcinoma in 1. Three cases 
of the 4 adenocarcinomas were bronchioloalveolar carcinoma. Of the 
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46 cases in which the diagnosis was determined with only cytology, 9 
cases were different in diagnosis between cytology and pathology. Sev-
en cases were different only in cell typing of primary lung cancer. One 
case diagnosed as primary lung cancer by cytology was diagnosed as 
metastatic lung cancer from colon cancer by pathology. The other case 
diagnosed as metastatic lung cancer from breast cancer was diagnosed 
as primary lung cancer by pathology. There were no false positive cases 
regarding malignancy.
Conclusion: These results suggest that intra-operative FNA cytology 
with the modiﬁed Shorr’s staining method is useful for diagnosing 
malignancy-suspected pulmonary nodules in clinical practice.
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Introduction: A few prospective studies concerning diagnosis and 
treatment of large cell neuroendocrine lung cancer were published, as 
this tumor seems relatively rare. The objectives of GFPC 03-02 pro-
spective study were to establish the efﬁciency of Cisplatinum /Etopo-
side chemotherapy and to valid value of large spectrum cytokeratins in 
the diagnosis of neuro-endocrine differnciation.
Methods: Patients with stage IV and stage III B (with neoplasic pleural 
effusion) were included; treatment consisted in three cycles of Cisplati-
num 80mg/m2 d1 / Etoposide 100mg/m2 d1d2d3 and two more cycles 
in case of objective response or stable disease.
The primary objective is the efﬁciency of this chemotherapy, second-
ary objective the validation of the paranuclear granular expression of 
a large spectrum cytokeratin, as a characteristic of neuro-endocrine 
differentiation. Slides were controlled by a panel of pathologists. Diag-
noses were based on Travis’s criterias.
Results: 27 patients were included since May 2004. The slides of 21 
cases were reviewed. 14 cases were conﬁrmed as LCNEC. 4 were 
excluded on the basis of the nuclear criteria or cell size, and classiﬁed 
as small-cell carcinomas (SCC). One was excluded, because immuno-
histochemistry was not available. Two other patients were excluded be-
cause of the misinterpretation of the pathologic report by the clinicians 
(one SCC, one Large cell Carcinoma).
Among the 14 cases, two sub-types were observed:
- 8 LCNEC with neuroendocrine features and positive immunohisto-
chemistry
- 6 undifferentiated carcinomas with immunohistochemical neuroen-
docrine differentiation.
None case was diagnosed as large-cell carcinoma with neuroendocrine 
pattern and negative immunohistochemistry.
Table 1. Immunohistochemical results
Antibodies Positive Negative Not Evaluated
Cytokeratin (AE1/AE3 or KL1 or MNF116) 5 2 7
Chromogranin A 12 0 2
Synaptophysin 12 0 2
CD56 6 3 5
TTF1 7 2 5
In all cases, at least two of the three neuroendocrine markers (chromo-
granin A, synaptophysin, CD56) were positive.
Discussion: Interobserver variability is not observed on the criterias 
of neuroendocrine immunohistochemical differentiaton, but only on 
the criterias of size. Some small scratched samples led to difﬁculties to 
distinguish small-cell carcinoma from large-cell carcinoma, especially 
when neuroendocrine morphology (rosettes, trabecular growth pat-
tern,…) was not present. It seems necessary to deﬁnite how many of 
the Travis’s criterias are necessary to accept the diagnosis of LCNEC 
(cell size, chromatin, nucleoli, nuclear-to-cytoplasmic ratio, large and 
eosinophilic or granular cytoplasm) when neuroendocrine differen-
tiation is proved. This interobserver variability is described in the 
literature (1).
Value of the paranuclear granular expression with Cytokeratins must be 
evaluated on cases not yet tested.
Conclusion: Panel of pathologists is useful to diagnose LCNEC. Dis-
agrements were on cell size, some LCNEC were reclassiﬁed as SCC. 
Usefulness of cytokeratins needs some more patients tested.
(1) W.D.Travis, A.A. Gal, T.V. Colby and coll. Reproductibility of neu-
roendocrine lung tumor classiﬁcation. Hum Pathol 1998, 29: 272-279
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Stromal invasion of cancer is associated with proliferation of stromal 
myoﬁbroblasts. These cells are considered as activated ﬁbroblasts that 
facilitate invasion and metastasis of cancer cells. Myoﬁbroblasts in ear-
ly lung adenocarcinoma lesions, such as pure bronchiolo-alveolar carci-
noma (BAC) and mixed type adenocarcinoma with a BAC component, 
are not well documented in the literature. We report here the presence 
of subepithelial myoﬁbroblasts in pure bronchiolo-alveolar carcinoma 
(BAC) and a subset of invasive lung adenocarcinomas. We also charac-
terized their immunohistochemical proﬁles, investigated their relation-
ships with stromal invasion and the prognostic signiﬁcance.
Materials and Methods: A total of 75 cases of surgically resected lung 
adenocarcinomas were examined. There were 9 cases of BAC, 14 cases 
of mixed type adenocarcinoma with a BAC component, and 52 cases 
of pure invasive adenocarcinomas. All cases were immunostained for 
smooth muscle α-actin to visualize myoﬁbroblasts. Selected cases were 
also stained for calponin, desmin and h-caldesmon. 
Results: In all cases of pure BACs, we could observe subepithelial 
myoﬁbroblasts. These cells were characterized by their peculiar loca-
tion between cancer cells and alveolar septa. Immunohistochemically, 
they were positive for smooth muscle α-actin and calponin. Some were 
